Literature DB >> 23836741

Value-based insurance design: quality improvement but no cost savings.

Joy L Lee1, Matthew Maciejewski, Shveta Raju, William H Shrank, Niteesh K Choudhry.   

Abstract

Value-based insurance design (VBID) is an approach that attempts to improve the quality of care by selectively encouraging or discouraging the use of specific health care services, based on their potential benefit to patients' health, relative to their cost. Lowering beneficiary cost sharing or out-of-pocket spending to increase medication adherence is one common element of value-based insurance design. We conducted a systematic review of the peer-reviewed literature to evaluate the evidence of the effects of VBID policies on medication adherence and medical expenditures. We identified thirteen studies assessing the effects of VBID programs and found that the programs were consistently associated with improved adherence (average change of 3.0 percent over one year), as well as with lower out-of-pocket spending for drugs. In the studies we reviewed, providing more generous coverage did not lead to significant changes in overall medical spending for patients and insurers. Further research is needed to understand how best to structure VBID programs to both improve quality and reduce spending.

Entities:  

Keywords:  Health Reform; Insurance Coverage; Pharmaceuticals; Quality Of Care

Mesh:

Year:  2013        PMID: 23836741     DOI: 10.1377/hlthaff.2012.0902

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  21 in total

1.  Consumers' Valuation of Primary Care-Based Treatment Options for Mental and Substance Use Disorders.

Authors:  Andrew J Epstein; Colleen L Barry; David A Fiellin; Susan H Busch
Journal:  Psychiatr Serv       Date:  2015-05-01       Impact factor: 3.084

2.  Capsule Commentary on Duru et al., Adherence to Metformin, Statins, and ACE/ARBs Within the Diabetes Health Plan (DHP).

Authors:  R Brett McQueen
Journal:  J Gen Intern Med       Date:  2015-11       Impact factor: 5.128

Review 3.  Behavioral Economic Insights to Improve Medication Adherence in Adults with Chronic Conditions: A Scoping Review.

Authors:  Jacqueline Roseleur; Gillian Harvey; Nigel Stocks; Jonathan Karnon
Journal:  Patient       Date:  2019-12       Impact factor: 3.883

4.  Value-Based Insurance Design: Aligning Incentives to Improve Cardiovascular Care.

Authors:  Eric C Stecker; John Z Ayanian; A Mark Fendrick
Journal:  Circulation       Date:  2015-10-20       Impact factor: 29.690

5.  Opportunities to Enhance Value-Related Research in the U.S. Department of Veterans Affairs.

Authors:  Todd H Wagner; Helen Burstin; Austin B Frakt; Sarah L Krein; Karl Lorenz; Matthew L Maciejewski; Steven D Pizer; Michael Weiner; Jean Yoon; Donna M Zulman; Steven M Asch
Journal:  J Gen Intern Med       Date:  2016-04       Impact factor: 5.128

6.  Improving adherence to high-value medications through prescription cost-sharing policies.

Authors:  Melissa M Garrido; Austin B Frakt
Journal:  BMJ Qual Saf       Date:  2018-04-19       Impact factor: 7.035

7.  Reforming medicare's dialysis payment policies: implications for patients with secondary hyperparathyroidism.

Authors:  Charu Gupta; Glenn M Chertow; Mark T Linthicum; Karen Van Nuys; Vasily Belozeroff; Darryl Quarles; Darius N Lakdawalla
Journal:  Health Serv Res       Date:  2014-07-07       Impact factor: 3.402

8.  Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.

Authors:  Kai Yeung; Anirban Basu; Ryan N Hansen; John B Watkins; Sean D Sullivan
Journal:  Med Care       Date:  2017-02       Impact factor: 2.983

9.  High-Deductible Insurance and Delay in Care for the Macrovascular Complications of Diabetes.

Authors:  J Frank Wharam; Christine Y Lu; Fang Zhang; Matthew Callahan; Xin Xu; Jamie Wallace; Stephen Soumerai; Dennis Ross-Degnan; Joseph P Newhouse
Journal:  Ann Intern Med       Date:  2018-11-20       Impact factor: 25.391

Review 10.  Medication adherence and heart failure.

Authors:  Eric M Riles; Anuja V Jain; A Mark Fendrick
Journal:  Curr Cardiol Rep       Date:  2014-03       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.